Dabrafenib and Pazopanib Hydrochloride in Treating Patients With Advanced Malignant Tumors
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-10-25
- Last Posted Date
- 2019-03-01
- Lead Sponsor
- Manisha Shah
- Target Recruit Count
- 23
- Registration Number
- NCT01713972
- Locations
- 🇺🇸
Ohio State University Medical Center, Columbus, Ohio, United States
🇺🇸University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States
© Copyright 2024. All Rights Reserved by MedPath